ONC Q1 2022 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q1 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$307M-49.4% YoY

Gross Profit

$241M78.7% margin

Operating Income

-$443M-144.6% margin

Net Income

-$435M-141.9% margin

EPS (Diluted)

$-4.29

QoQ Revenue Growth

+43.3%

Cash Flow

Operating Cash Flow

-$237M

Free Cash Flow

-$357M

Stock-Based Comp.

$66M

Balance Sheet

Total Assets

$8.0B

Total Liabilities

$2.1B

Stockholders' Equity

$5.9B

Cash & Equivalents

$4.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$307M	$606M	-49.4%
Gross Profit	$241M	$573M	-57.9%
Operating Income	-$443M	$70M	-731.8%
Net Income	-$435M	$66M	-754.5%